Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (TSX:LABS)

0.0650 -0.0050 (-7.14%)
Streaming Delayed Price Updated: 1:23 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medipharm Labs Corp

News headline image
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago ↗
Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap. 
Via Benzinga
Topics Cannabis
News headline image
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth ↗
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024... 
Via Benzinga
News headline image
MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY ↗
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an... 
Via Benzinga
Topics Cannabis
News headline image
This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now ↗
Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,... 
Via Benzinga
Topics Cannabis
News headline image
Executive Changes In Cannabis Industry You Should Know About, New Appointments & More ↗
Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as... 
Via Benzinga
Topics Cannabis
News headline image
Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method ↗
Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to... 
Via Benzinga
Topics Cannabis
News headline image
Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' ↗
 
Via Benzinga
News headline image
This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses ↗
Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,... 
Via Benzinga
News headline image
Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil ↗
Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products... 
Via Benzinga
Topics Cannabis
News headline image
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 ↗
This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and... 
Via Benzinga
Topics Cannabis
News headline image
MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report ↗
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of... 
Via Benzinga
News headline image
MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M ↗
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis 
Via Benzinga
News headline image
MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next ↗
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C. 
Via Benzinga
News headline image
MediPharm Labs Sees 16.5% QoQ Increase In International Medical Cannabis Sales, Announces New CEO ↗
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX:LABS... 
Via Benzinga
Topics Cannabis
News headline image
MediPharm Labs Taps Bryan Howcroft as Chief Executive Officer And Director ↗
MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
Via Benzinga
News headline image
MediPharm Labs To Provide Materials For Clinical Trial On CBD For Insomnia ↗
MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
Via Benzinga
News headline image
MediPharm Labs Reports 24% QoQ Pop In International Sales, Q2 2021 Revenue Drops 63.6% YoY ↗
MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
Via Benzinga
News headline image
MediPharm Labs Receives Canadian GMP Pharmaceutical Drug Establishment License ↗
Pharmaceutical company MediPharm Labs Corp. (TSX:LABS) (OTCQX... 
Via Benzinga
News headline image
MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma ↗
MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
Via Benzinga
Topics Cannabis
News headline image
MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know ↗
MediPharm Labs Corp. (TSX:LABS) (OTCQX: 
Via Benzinga
Topics Cannabis
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.